While no preclinical models have been reported to exhibit this behavior, it seems likely that this will be driven by marked transcriptional reprogramming similar to induction of EMT where switching to the SCLC lineage would relieve cancer cells of their dependence on mutant EGFR. The gene discussed is EGFR; the disease is small cell lung carcinoma.